Revenue Comparison
Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Eli Lilly 22.974, Amgen 8.618.
Eli Lilly vs Amgen Net Worth and Market Cap
Eli Lilly (LLY) and Amgen (AMGN) are peers in GLP-1. Eli Lilly reported revenue of $23.0B as of Q2 2026, compared with $8.6B for Amgen. Eli Lilly leads on revenue.
Eli Lilly's gross margin is 85.8% versus 68.2% for Amgen. Eli Lilly's net margin is 30.9% versus 21.1% for Amgen.
Key differences
- Revenue growth on the same quarter a year earlier: Eli Lilly +47.7% (Q2 2026), Amgen +5.8% (Q1 2026).
- Eli Lilly keeps more of its revenue as operating profit: a 54.2% operating margin, against 30.9% at Amgen.
- Eli Lilly's KPIs on Sterling include Cardiometabolic Manufacturing Capex Announcements by Site (Cumulative) and Foundayo Quarterly Revenue.
- Amgen's KPIs on Sterling include AMG 513 Obesity Discontinuation and Cash and Cash Equivalents.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Amgen.| Metric | Eli Lilly | Amgen |
|---|---|---|
| Market Cap | - | - |
| Revenue | $22.97B | $8.62B |
| Cost of Revenue | $3.27B | $2.74B |
| Gross Profit | $19.71B | $5.87B |
| Operating Income | $12.46B | $2.67B |
| Net Income | $7.09B | $1.82B |
| R&D Expense | $3.82B | $1.72B |
| Earnings Per Share | $7.94 | $3.34 |
| Gross Margin | 85.8% | 68.2% |
| Operating Margin | 54.2% | 30.9% |
| Net Profit Margin | 30.9% | 21.1% |
| Free Cash Flow | $7.76B | $1.48B |
| Cumulative Free Cash Flow | $109.66B | $165.69B |
| Operating Cash Flow | $10.69B | $2.19B |
| Cash & Equivalents | $8.89B | $12.04B |